Development of superior polymerases for next-generation mrna therapeutic & vaccine manufacturing
Ended Project Grant Awarded Last action
- Award ID
- R44GM131548
- Recipient
-
Primrose Bio, Inc. UEI Y5AJZF5JMRD4
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,621,333
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $469,286 | |
| Original award | $1,152,047 |
Quick answers
Who received award R44GM131548?
R44GM131548 was awarded to Primrose Bio, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on August 5, 2020.
How much is award R44GM131548 worth?
$1,621,333 has been obligated on R44GM131548.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award